Inter Pharma PCL

Inter Pharma PCL ROE

The Return on Equity (ROE) of Inter Pharma PCL (IP.BK) as of Nov 3, 2026 is 5.94 %. In the previous year, Return on Equity (ROE) was 1.92 % — a change of 208.79% (higher).

ROE

5.94 %

YoY

208.79%

Last updated:

In 2025, Inter Pharma PCL's return on equity (ROE) was 5.94 %, a 208.79% increase from the 1.92 % ROE in the previous year.

The Inter Pharma PCL ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
29.52 THB
Jan 1, 2019
9.54 THB
Jan 1, 2020
11.15 THB
Jan 1, 2021
13.81 THB
Jan 1, 2022
6.17 THB
Jan 1, 2023
2.65 THB
Jan 1, 2024
1.92 THB
Jan 1, 2025
5.94 THB
The Inter Pharma PCL ROE history
YEARROEYoY
5.94 %+208.79%
1.92 %-27.49%
2.65 %-56.98%
6.17 %-55.33%
13.81 %+23.87%
11.15 %+16.91%
9.54 %-67.68%
29.52 %+37.59%
21.45 %-49.26%
42.28 %-34.87%
64.91 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Inter Pharma PCL Stock analysis

What does Inter Pharma PCL do? Inter Pharma PCL is one of the most popular companies on Eulerpool.

ROE Details

Decoding Inter Pharma PCL's Return on Equity (ROE)

Inter Pharma PCL's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Inter Pharma PCL's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Inter Pharma PCL's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Inter Pharma PCL’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Inter Pharma PCL stock

Return on Equity (ROE) of Inter Pharma PCL is 5.94 % in 2025.

Return on Equity (ROE) of Inter Pharma PCL changed from 1.92 % to 5.94 %, representing a 208.79% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Inter Pharma PCL since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Inter Pharma PCL with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Inter Pharma PCL

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Inter Pharma PCL